Fall and rise of polypharmacy?

Hypertension

Volumn 49, Issue 2, 2007, Pages 266-267

  Reid, John L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; INDAPAMIDE; INDAPAMIDE PLUS PERINDOPRIL; METHYLDOPA; PERINDOPRIL; PROPRANOLOL; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

BLOOD PRESSURE REGULATION; COMBINATION CHEMOTHERAPY; DRUG DOSE TITRATION; DRUG FORMULATION; DRUG MEGADOSE; HUMAN; HYPERTENSION; MEDICAL SCHOOL; MONOTHERAPY; NOTE; POLYPHARMACY; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; CARDIOLOGY; HUMANS; HYPERTENSION; POLYPHARMACY;

EID: 33846410263     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000254485.43156.02     Document Type: Note

References (6)

1. Zacest R, Gilmore E, Koch-Weser J. Treatment of essential hypertension with combined vasodilation and beta adrenergic blockade. N Engl J Med. 1972;286:617-622.
2. Reid JL. The treatment of hypertension: a therapeutic philosophy for the 1990s. J Cardiovasc Pharmacol. 1991;18(suppl 2):S64-S67.
3. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326:1419-1424.
4. Myers MG, Asmar R, Leenen FH, Safar M. Fixed low-dose combination therapy in hypertension - a dose response study of perindopril and indapamide. J Hypertens. 2000;18:317-325.
5. Law MR, Wald NJ, Morris JL, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326:1427-1435.
6. Mahmud A, Feely J. Low-dose quadruple antihypertensive combination: more efficacious than individual agents-a preliminary report. Hypertension. 2007;49:272-275.